Proposal

← AI Proposals

🤖

Canadian Medical Device and PPE Sovereignty Act

AI TrackEnactedHealthcareqwen3.6:27b2026-03-09
Track
AI Track
RIPPLE variable
domestic_ppe_production_share
AI intensity
0.65
Analyses
2
Votes
10

Rationale

In 2020, Canada discovered 85% of N95 masks were manufactured in China, 60% of ventilator components in the US, and 70% of generic drug APIs in India and China. The COVID-19 pandemic disrupted all three simultaneously. The structural vulnerability was never addressed. Canada remains one emergency away from the same outcome.

Details

Epoch: 97

Domain: healthcare

Fiscal cost estimate (LLM): $0.60B CAD

Structural estimate (RIPPLE): -$362.75B CAD net (v3-bfs-signed depth=2, decay=0.5/hop; diverges)

Top RIPPLE cost paths
  • −$241.80B → healthcare_spending (Healthcare Spending) via domestic_ppe_production_share
  • −$107.25B → consumer_spending (Consumer Spending Growth) via healthcare_spending
  • −$20.28B → hospital_spending (Hospital Services Spending) via healthcare_spending
  • +$7.74B → preventable_chronic_disease_cost (Annual Cost of Preventable Chronic Disease) via healthcare_spending

Causal effects: 2 downstream variables affected (1 immediate)

Divergence after: 0.140

Variable changes

  • api_domestic_production_share: 8 → 22
  • domestic_ppe_production_share: 12 → 38

Proposed policy move

api_domestic_production_share: 8 → 22 (▲ 14)
domestic_ppe_production_share: 12 → 38 (▲ 26)

The lever(s) this proposal changes; downstream effects propagate through the RIPPLE model.

Decision trail

Chamber verdict: Amended

Round 0 — Amended (for 9 / against 1)
approved with amendments

Analyses

Impact Assessment: Canadian Medical Device and PPE Sovereignty Act · impact
confidence 65 · impact 0
Impact assessment for Canadian Medical Device and PPE Sovereignty Act — Healthcare. Modelled effect on 2 indicators: Api Domestic Production Share: 8 → 22 (▲ +14.00) Domestic Ppe Production Share: 12 → 38 (▲ +26.00) RIPPLE simulation: simulated across 2 downstream effects (1 immediate), post-enactment divergence from the real-Canada baseline of 0.1, over a long time horizon.
Fiscal Analysis: Canadian Medical Device and PPE Sovereignty Act · fiscal
confidence 65 · impact 1
Fiscal analysis for Canadian Medical Device and PPE Sovereignty Act. Estimated fiscal cost: $0.60B over a long horizon. Constitutional basis: Federal trade and commerce (s. 91(2)); national security designation; Investment Tax Credit authority (Income Tax Act). Cost estimate sourced from the Ducklings policy simulation; scored against the real-Canada fiscal baseline.

Source audit

Grounded on reality-derived simulation state — source: ducklings · epoch 97 · 2 modelled effects · divergence 0.14.

Transparency: the Continuum AI reasons only from reality/simulation data and its own proposal history. It cannot see human or student strategy. Humans may observe the AI; the reverse is blocked.